FDA To Bolster Post-Approval Drug Oversight

Law360, New York (February 27, 2008, 12:00 AM EST) -- In the wake of a rash of recent drug recalls, the U.S. Food and Drug Administration reportedly is set to keep a closer eye on the use of medicines after they have reached the market, marking a shift from its traditional focus on pre-approval monitoring of new treatments.

The agency said it would start monitoring the use of medicines after they have been approved, as part of a larger safety initiative announced to staffers Tuesday, the Associated Press reported.

Under the new initiative, the FDA will...
To view the full article, register now.